Fig. 4From: Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancerThe expression of tissue biomarkers among three different neoadjuvant treatment groups. The mean immunoreactivity score in cancer and stromal cells among the three groups, including NNA, NHT, and CHT, are described. The statistical differences of the mean immunoreactivity score of NHT and CHT compared with NNA were statistically evaluated. *p < 0.05. Nuclear expression of a AR in residual cancer cells, b GR in residual cancer cells, c PR in stromal cells, and d YAP1 in residual cancer cellsBack to article page